- Report
- May 2025
- 197 Pages
Global
From €3155EUR$3,545USD£2,731GBP
€3506EUR$3,939USD£3,034GBP
- Report
- July 2025
- 389 Pages
Global
From €5207EUR$5,850USD£4,506GBP
- Report
- February 2025
- 185 Pages
Global
From €3404EUR$3,825USD£2,946GBP
€4005EUR$4,500USD£3,466GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1780EUR$2,000USD£1,541GBP
From €4361EUR$4,900USD£3,774GBP
- Report
- February 2025
- 200 Pages
Global
From €3996EUR$4,490USD£3,459GBP
- Report
- July 2025
- 181 Pages
Global
From €5207EUR$5,850USD£4,506GBP
- Report
- June 2025
- 200 Pages
Global
From €2482EUR$2,789USD£2,148GBP
- Report
- May 2024
- 137 Pages
Global
From €5784EUR$6,499USD£5,006GBP
- Report
- June 2024
- 200 Pages
Global
From €7076EUR$7,950USD£6,124GBP
- Report
- June 2024
- 145 Pages
Global
From €2225EUR$2,500USD£1,926GBP
- Report
- August 2022
- 243 Pages
Global
From €2225EUR$2,500USD£1,926GBP
Atherosclerosis is a condition in which the arteries become hardened and narrowed due to the buildup of plaque. Atherosclerosis drugs are used to treat this condition and are a major component of the cardiovascular drug market. These drugs are used to reduce the risk of heart attack, stroke, and other cardiovascular diseases. Commonly used drugs include statins, antiplatelet drugs, and fibrates. Statins are used to reduce cholesterol levels, while antiplatelet drugs are used to prevent blood clots. Fibrates are used to reduce triglyceride levels.
In addition to these drugs, lifestyle changes such as diet and exercise are also important in treating atherosclerosis. These changes can help reduce the risk of cardiovascular disease and improve overall health.
Companies in the Atherosclerosis Drug market include Pfizer, Merck, Sanofi, AstraZeneca, and Novartis. Show Less Read more
